Skip to main content

NuCana plc

For the period ended Dec 31, 2024. Filed Mar 20, 2025.

View on SEC.gov

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2024 · Filed Mar 20, 2025

NCNA$0.94+0.4%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Selected Financial Data

The following tables summarize our consolidated financial data as of the dates and for the periods indicated. The consolidated financial data as of and for the years ended December 31, 2024, 2023, 2022, 2021 and 2020 have been derived from our consolidated financial statements, which have been prepared in accordance with IFRS, as issued by the IASB, and audited in accordance with the standards of the Public Company Accounting Oversight Board (United States).

Our historical results are not necessarily indicative of the results that may be expected in the future. The following selected consolidated financial data should be read in conjunction with Item 5, “Operating and Financial Review and Prospects” and our consolidated financial statements included elsewhere in this Annual Report.

Year Ended December 31,
20242023202220212020
(in thousands, except per share data)
Consolidated statement of operations and comprehensive loss data:
Research and development expenses£(18,017)£(25,062)£(36,426)£(36,834)£(25,899)
Administrative expenses(4,988)(6,063)(7,291)(8,529)(7,050)
Impairment of intangible assets(33)(503)(292)(2,809)—
Net foreign exchange gains (losses)229(1,156)4,887267(3,472)
Operating loss(22,809)(32,784)(39,122)(47,905)(36,421)
Finance income358754669103246
Loss before tax(22,451)(32,030)(38,453)(47,802)(36,175)
Income tax credit3,4544,3986,4327,2695,493
Loss for the year(18,997)(27,632)(32,021)(40,533)(30,682)
Other comprehensive income (expense):
Items that may be reclassified subsequently to profit or loss:
Exchange differences on translation of foreign operations15(41)615(12)
Total comprehensive loss for the year£(18,982)£(27,673)£(31,960)£(40,528)£(30,694)
Basic and diluted loss per ordinary share£(0.26)£(0.53)£(0.61)£(0.78)£(0.81)
As of December 31,
20242023202220212020
(in thousands)
Consolidated statement of financial position data:
Cash and cash equivalents£6,749£17,225£41,912£60,264£87,356
Total assets14,77427,81158,25477,474107,792
Share capital5,6812,1142,0952,0872,047
Share premium146,146141,306141,108141,050140,890
Accumulated deficit(224,294)(207,706)(180,573)(149,726)(110,594)
Capital reserve (1)42,46642,46642,46642,46642,466
Net assets/Total equity attributable to equity holders of the Company5,95414,88738,50265,54899,230
Total liabilities(8,820)(12,924)(19,752)(11,926)(8,562)
Number of ordinary shares142,03752,86052,37352,18051,175

(1)

The capital reserve balance arose from the impact of the reduction of our share premium account and corresponding increase to our capital reserve account reflected as of June 30, 2017 in connection with our re-registration as a public limited company, as further described in Note 12 to the consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.